SCHEMBL4521076

SCHEMBL4521076

CC(C)Oc1ccc(C(=O)N(Cc2ccc(-c3ccccc3)cc2)NC(=O)NN)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CENPE Q02224 1/20 0.47
S1PR1 P21453 4/20 0.43
S1PR3 Q99500 2/20 0.43
KIFC1 Q9BW19 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CSNK2A1 P68400 2/20 0.40
LMNA P02545 1/20 0.38
RORC P51449 1/20 0.37
P2RX3 P56373 1/20 0.37
KMO O15229 2/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
MAP4K4 O95819 1/20 0.37
MINK1 Q8N4C8 1/20 0.37
S1PR5 Q9H228 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4721152 0.91 CENPE (0.52) CENPES1PR1S1PR3KIFC1MEN1
SCHEMBL4719991 0.89 CENPE (0.48) CENPES1PR1S1PR3KIFC1MEN1
SCHEMBL2101902 0.85 CENPE (0.51) CENPES1PR1S1PR3KIFC1MEN1
SCHEMBL2104964 0.82 CENPE (0.53) CENPES1PR1S1PR3KIFC1MEN1
SCHEMBL4722528 0.81 CENPE (0.53) CENPEMEN1KMT2ALMNARORC
SCHEMBL4718072 0.80 CENPE (0.46) CENPEMEN1KMT2AP2RX3CYP1A2
SCHEMBL2103268 0.80 CENPE (0.56) CENPES1PR1S1PR3KIFC1MEN1
SCHEMBL4720776 0.80 CENPE (0.44) CENPES1PR1S1PR3KIFC1MEN1
SCHEMBL5569249 0.79 CENPE (0.48) CENPES1PR1S1PR3KIFC1MEN1
SCHEMBL4721237 0.79 SPHK2 (0.44) CENPEKMT2ACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286841-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286841-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS KIF5B, KIF2C, PLK1 CENPE 54/4885S1PR1 2943/4885S1PR3 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.